Tyche Industries (532384)
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 1/1
Key Financials
| Current Price | ₹175.1 |
| Market Cap | ₹181.4 Cr |
| P/E Ratio | 17.45 |
| ROCE | 12.67% |
| ROE | 5.1% |
| Dividend Yield | 2.63% |
| Profit Growth | -61.6% |
| Debt/Equity | — |
| Sales Growth | -40.39% |
| 52-Week Range | ₹99 — ₹175.1 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹136.01 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let's look at Tyche Industries without romance. A pharmaceutical company with a ₹181 crore market cap, trading at ₹175.10 — at the very top of its 52-week range. Yet reported sales fell 40.39% and profits fell 61.60%. That combination makes no sense to me unless the market is betting on a sharp recovery. I don't bet on hope.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer